Pharmacology funding

Doctoral students or researchers awarded a doctorate in 2022 or later, employed or enrolled at a current SASUF+ partner university throughout the placement. The host must be a current partner university in the other country, with an invitation and home-supervisor or manager approval. Former partner institutions are not automatically eligible.

Mid-career researchers apply through an eligible Australian administering organisation. The PhD award date must fall between 1 March 2012 and 1 March 2022, or be equivalent after allowable career interruptions. A maximum of three applications is permitted. ARC medical-research exclusions apply.

Applicants must be based at a research organisation eligible for Medical Research Council funding and propose a high-risk development step for a medical product that builds on prior funded work.

PhD completed no more than three years, or equivalent full-time years, before the deadline. Research must have been mainly undertaken in Tasmania or under a Tasmanian organisation. Anyone may nominate another person; self-nominations are excluded.

Applicants should have or expect a first or high upper-second-class degree, or overseas equivalent, with appropriate biochemistry and cell-biology knowledge. Home-rate fees are funded. Overseas applicants must qualify for Home fees or secure separate scholarship funding for the fee difference; self-funding that difference is not permitted.

Applicants to the TTP-T and TTP-P tracks must follow the current NSF 25-540 organizational and submission requirements.

An Austrian research institution applies for a researcher whose ERC Starting Grant 2026 proposal with that institution received an A rating but was not funded for budgetary reasons. Permanent professors or equivalent leaders, accepted permanent-professorship appointees, and former FWF START, ASTRA or ERC Starting Grant recipients are ineligible. ASTRA application rules also apply.

At least three independent entities in three different EU Member States or Horizon Europe associated countries, including at least one EU Member State. Austria is eligible. This call is for organisations, not individual students. Doctoral recruits must meet the programme’s degree and mobility rules.

Swedish citizens or permanent residents who received a doctorate within the past six years, or doctoral students expecting the degree within two years, may apply through this route. A host researcher at an eligible Japanese university or research institution is required. All academic fields are eligible.

Postdoctoral applicants normally within four years of the doctorate; experienced researchers within twelve years, with an independent publication record and a leadership role. German host agreement, facilities confirmation and assessment required. Prior Humboldt sponsorship excludes this route. Apply under the joint CAPES-Humboldt procedure.

The coordinator must hold a PhD and work at an Austrian member institution. Include at least one Austrian and one African member, all with 2026 fees paid. Participants must be PhD students or graduates. One proposal per coordinator; institutional endorsements and own funding are required.

Women founders or co-founders apply as individuals. Both residence and company establishment must be in an EU member state or Horizon Europe associated country. The company must have been incorporated before 1 January 2025. Only one prize category may be entered.

Canadian citizens, permanent residents or Protected Persons; eligible research graduate programme at an allocated Canadian institution. Normally 0–12 months of study by December 31; specific transition rules apply. First-class grades normally required, with institutional discretion. Prior agency master’s awards and specified Indigenous master’s awards exclude eligibility; only one CRTAS application per academic year.

University partnerships require eligible Canadian academics, non-academic partners and qualifying NSERC partnership-grant support in natural sciences or engineering. College partnerships require an eligible Canadian college, non-academic partners and implementation of results from a previous College and Community Innovation grant; broader research disciplines qualify. Self-nominations are excluded. A college research grants officer cannot nominate; previous Herzberg laureates are ineligible.

Applicants need or should expect a first or upper-second-class degree, or overseas equivalent, in a subject that prepares them for cell-biology research. UK citizens and overseas applicants meeting Home-fee requirements may apply; other overseas applicants need additional scholarship funding for the fee difference. Self-funding the difference is not allowed.

International students commencing or enrolled in a higher degree by research may apply. New applicants must submit a complete admission application and a separate scholarship application by the deadline; enrolled applicants submit the scholarship form.

Researchers of any nationality with 5–15 years since their certified successful PhD defence, subject to the 2027 call reference date and permitted extensions. A committed host in an eligible EU Member State or associated country must support an independent research team.

A UK organisation eligible for MRC funding must lead. International researchers may participate as international co-leads under MRC rules. Businesses and most charities participate as partners rather than leads.

Consortia must include at least one existing business and one research organisation. Businesses need a completed annual accounting period and at least 40% of the project budget. Research must take place in Attica and match the region’s RIS3 priorities.

Organisations with standard MRC eligibility; normally UK-based project leads, with the stated MRC Gambia and Uganda unit exceptions. One application per project lead; source rules restrict resubmissions.